TBPH icon

Theravance Biopharma

121 hedge funds and large institutions have $431M invested in Theravance Biopharma in 2024 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 35 increasing their positions, 47 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding:

more ownership

Funds ownership:

less call options, than puts

Call options by funds: $ | Put options by funds: $

20% less funds holding in top 10

Funds holding in top 10: 54 (-1)

22% less capital invested

Capital invested by funds: $552M → $431M (-$121M)

26% less repeat investments, than reductions

Existing positions increased: 35 | Existing positions reduced: 47

Holders
121
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
4
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$22K
Puts
$23K
Net Calls
Net Calls Change

Top Sellers

1 -$7.4M
2 -$7.21M
3 -$3.4M
4
Jane Street
Jane Street
New York
-$3.03M
5
NM
Newtyn Management
New York
-$2.3M
Name Holding Trade Value Shares
Change
Change in
Stake
26
$1.59M
27
$1.45M
28
$1.45M
29
$1.43M
30
$1.18M
31
$1.13M
32
$1.07M
33
$1.04M
34
$1.04M
35
$1M
36
$827K
37
$724K
38
$661K
39
$652K
40
$599K
41
$596K
42
$579K
43
$557K
44
$556K
45
$546K
46
$538K
47
$530K
48
$529K
49
$522K
50
$470K